Evidence map›Paper›PMID 41589254›Full record

ArticleInternational cancer conference journal2026

A case of neuroendocrine carcinoma of the urachal cancer with comprehensive genomic profiling results.

Shunsuke Owa, Takeshi Sasaki, Kenta Matsui, Taketomo Nishikawa, Momoko Kato, Takumi Kageyama, Hiroto Yuasa, Shinichiro Higashi, Yusuke Sugino, Yasutaka Tono and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shunsuke OwaDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Takeshi SasakiDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Kenta MatsuiPathology Division, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Taketomo NishikawaDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Momoko KatoDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Takumi KageyamaDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Hiroto YuasaPathology Division, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Shinichiro HigashiDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Yusuke SuginoDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Yasutaka TonoDepartment of Medical Oncology, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Takumi FujiwaraDepartment of Genomic Medicine, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Akinobu HayashiPathology Division, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Kouhei NishikawaDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Hiroshi ImaiPathology Division, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Yoshinaga OkugawaDepartment of Genomic Medicine, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Toshiro MizunoDepartment of Medical Oncology, Mie University Hospital, 174-2, Edobashi, Tsu, Mie 514-8507 Japan.
Takahiro InoueDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.ORCID 0000-0001-8586-784X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urachal cancer is a rare malignancy, and cases with neuroendocrine features are extremely uncommon. We present a man in his 30s with gross hematuria. Imaging revealed a nodular mass in the bladder dome with lung metastases. Histopathology after transurethral and open resection revealed a large cell neuroendocrine carcinoma arising from the urachus. Comprehensive genomic profiling (CGP) identified

Indexed as

Comprehensive genomic profilingFGFR2–TACC2 fusionNeuroendocrine carcinomaUrachal cancer

Identifiers

PMID41589254
PMCPMC12831707

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.